Action from the CRM: barbiturates
- 1 February 1980
- journal article
- research article
- Published by BMJ in Drug and Therapeutics Bulletin
- Vol. 18 (3) , 9-11
- https://doi.org/10.1136/dtb.18.3.9
Abstract
In 1975 the Committee on the Review of Medicines (CRM) began to examine the efficacy and safety of those drugs that were already on the market before 1971, when the present licensing procedures were introduced.1It has already made recommendations on non-steroidal anti-inflammatory drugs2and on other drugs used in rheumatic diseases,3and these led to improvements in the data sheets for these products but had no obvious effects in practice. However, with its most recent recommendations on barbiturates, the CRM is showing its teeth.Keywords
This publication has 0 references indexed in Scilit: